Navigation Links
Thalidomide is the new approved drug for treating multiple cancers

Therapeutic Goods Administration (TGA) had approved the drug for use to treat the cancer multiple myeloma in 2003. This was revealed by a spokeswoman for the Department of Health and Ageing. It is available through Pharmaceutical Benefits Scheme.//

"The next step with any drug is to go to the PBS," as said by the spokesperson.

The history of the drug use reveals that the drug was originally used in Australia in the late 1950s and early 1960s to treat morning sickness and as a sedative but was taken off market around the world after it caused birth defects and miscarriages.

"The drug fell into disrepute because of miscarriages and its effect on the unborn child, however over the years it has been found to be very effective drug for other things," she said.

Even now the drug comes with a strict warning not to be used by pregnant women, women planning to become pregnant, or the male partners of women who are planning to become pregnant. "The TGA approved the drug under strict regulations," she said.


'"/>




Page: 1

Related medicine news :

1. Thalidomide may stage a comeback
2. Thalidomide for Tumor Treatment
3. Abortion Pill approved by FDA
4. Another injectable contraceptive Pill approved by FDA
5. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
6. New oral antiviral treatment of cold sores approved
7. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
8. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
9. Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki
10. IGF-1 drug approved by FDA
11. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2017)... ... August 19, 2017 , ... “Congratulations! It's A Boy! ... children to both their parents and God. “Congratulations! It's A Boy! God’s Gift: A ... a couple from Long Island, New York. , Published by Christian Faith Publishing, Dale ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... handheld devices. Through an educational webinar, they will present the line of epMotion ... to learn how easy you can automate everyday pipetting tasks. , Ideal for ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
(Date:8/18/2017)... ... 2017 , ... The Golseth Agency, a Texas based insurance management and financial ... regional charity campaign organized to provide support to Christina Upchurch and her two children ... and her children returned from out of town to find her husband passed away ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... HIGH POINT, N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., ... epilepsy is rumored to be in the beginning stages of an IPO. ... billion annually on epilepsy medications with the average cost of a prescription ... ... Another staggering figure is ...
(Date:8/11/2017)... Israel , Aug. 11, 2017 DarioHealth ... with mobile health and big data solutions, today announced ... on Monday, August 14 and host a conference call ... quarter 2017 operating and financial results and its strategy ... will be hosted by Erez Raphael , Chief ...
(Date:8/7/2017)... , Aug. 7, 2017 Insightin ... member acquisition, retention, and engagement, announced the selection ... Strategy and Product Development, effective as of February 2017. ... and technology implementation strategy for our clients. Wood ... experience in consulting and business analytics within the ...
Breaking Medicine Technology: